Epilepsy: Modern Treatment Approaches, Clinical Aspects, and Patent Status

Epilepsy is a chronic neurological disorder causing recurrent seizures. Improved diagnosis and management, including high-resolution imaging, genetic testing, and newer antiepileptic drugs with better efficacy and fewer side effects, have enhanced patient outcomes. For those who do not respond well to medication, surgeries like temporal lobe resection, corpus callosotomy, and laser interstitial thermal therapy are effective. Treatments that alter brain communication, such as vagus nerve stimulation (VNS), Deep Brain Stimulation (DBS), and Responsive Neurostimulation (RNS), also help control seizures. Precision medicine chooses the right treatment for each person based on specific biomarkers. Artificial intelligence helps predict seizures and refine treatment plans. Nanotechnology improves how drugs reach the brain and controls their release. These advances integrate medicine, surgery, and technology to provide personalized treatments, improving outcomes for those with epilepsy. Finally, dietary treatments, such as the ketogenic diet and modified Atkins diet, have been successful in reducing seizure activity, especially in children. Additionally, new studies on plant-based treatments have found that several medicinal herbs have antiepileptic properties. This suggests there may be natural alternatives to pharmaceutical drugs. These broad-based advances are a step toward an even broader and more tailored approach to epilepsy treatment, integrating pharmacologic, surgical, and technological progress. Upcoming trials and research must further develop these treatments, holding out new hope for epilepsy sufferers and further enhancing the long-term outlook. This systematic review points to paradigm-breaking progress in the treatment of epilepsy that has revolutionized therapeutic trends from 2001 to 2025. By synthesizing evidence of pharmacological innovation, surgical advancement, neuromodulation innovation, and precision medicine approaches, we seek to bridge crucial knowledge gaps between state-of-the-art research and clinical practice.

Authors

Institutions

Publication Details

Journal
CNS & Neurological Disorders - Drug Targets
Published
2026-03-13
DOI
https://doi.org/10.2174/0118715273408076251118070427
Primary Topic
Diet and metabolism studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Epilepsy: Modern Treatment Approaches, Clinical Aspects, and Patent Status

Alok Pratap Singh, Anchal Tyagi
CNS & Neurological Disorders - Drug Targets
Diet and metabolism studies
article

Epilepsy: Modern Treatment Approaches, Clinical Aspects, and Patent Status

Alok Pratap Singh, Anchal Tyagi
article en

Abstract

Epilepsy is a chronic neurological disorder causing recurrent seizures. Improved diagnosis and management, including high-resolution imaging, genetic testing, and newer antiepileptic drugs with better efficacy and fewer side effects, have enhanced patient outcomes. For those who do not respond well to medication, surgeries like temporal lobe resection, corpus callosotomy, and laser interstitial thermal therapy are effective. Treatments that alter brain communication, such as vagus nerve stimulation (VNS), Deep Brain Stimulation (DBS), and Responsive Neurostimulation (RNS), also help control seizures. Precision medicine chooses the right treatment for each person based on specific biomarkers. Artificial intelligence helps predict seizures and refine treatment plans. Nanotechnology improves how drugs reach the brain and controls their release. These advances integrate medicine, surgery, and technology to provide personalized treatments, improving outcomes for those with epilepsy. Finally, dietary treatments, such as the ketogenic diet and modified Atkins diet, have been successful in reducing seizure activity, especially in children. Additionally, new studies on plant-based treatments have found that several medicinal herbs have antiepileptic properties. This suggests there may be natural alternatives to pharmaceutical drugs. These broad-based advances are a step toward an even broader and more tailored approach to epilepsy treatment, integrating pharmacologic, surgical, and technological progress. Upcoming trials and research must further develop these treatments, holding out new hope for epilepsy sufferers and further enhancing the long-term outlook. This systematic review points to paradigm-breaking progress in the treatment of epilepsy that has revolutionized therapeutic trends from 2001 to 2025. By synthesizing evidence of pharmacological innovation, surgical advancement, neuromodulation innovation, and precision medicine approaches, we seek to bridge crucial knowledge gaps between state-of-the-art research and clinical practice.

CNS & Neurological Disorders - Drug TargetsVol. 25
SRM Institute of Science and Technology (IN)
Industry, innovation and infrastructure
Openalex Percentile: Top 21%
Diet and metabolism studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Epilepsy: Modern Treatment Approaches, Clinical Aspects, and Patent Status — Alok Pratap Singh, Anchal Tyagi · CNS & Neurological Disorders - Drug Targets (2026) | TGRS Research Map | TGRS